8 March 2013 In vivo optical activation of astrocytes as a potential therapeutic strategy for neurodegenerative diseases
Author Affiliations +
Abstract
Neurovascular dysfunction in many neurodegenerative diseases, such as Alzheimer’s disease (AD), reduces blood flow to affected brain areas and causes neuronal dysfunction and loss. A new optical imaging technique is developed to activate astrocytes in live animal models in order to investigate the increase of local cerebral blood flow as a potential therapeutic strategy for AD. The technique uses fluorescent labeling of vasculature and astrocytes coupled with intravital 2-photon microscopy to visualize the astrocyte-vasculature interactions in live animals. Using femtosecond laser stimulation, calcium uncaging is applied to specifically target and activate astrocytes in vivo with high spatial and temporal resolutions. Intravital 2-photon microscopy imaging was employed to demonstrate that single endfoot optical activation around an arteriole induced a 25% increase in arteriole diameter, which in turn increased cerebral local blood flow in down-stream capillaries. This quantitative result indicates the potential of using optical activation of astrocytes in afflicted brain areas of neurodegeneration to restore normal neurovascular functions.
© (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yuanxin Chen, Yuanxin Chen, James Mancuso, James Mancuso, Zhen Zhao, Zhen Zhao, Xuping Li, Xuping Li, Zhong Xue, Zhong Xue, Stephen T. C. Wong, Stephen T. C. Wong, } "In vivo optical activation of astrocytes as a potential therapeutic strategy for neurodegenerative diseases", Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 85655K (8 March 2013); doi: 10.1117/12.2004712; https://doi.org/10.1117/12.2004712
PROCEEDINGS
9 PAGES


SHARE
Back to Top